Workflow
Delcath(DCTH)
icon
Search documents
Delcath(DCTH) - 2022 Q2 - Quarterly Report
2022-08-07 16:00
Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par value per share DCTH The NASDAQ Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ ...
Delcath(DCTH) - 2022 Q1 - Earnings Call Transcript
2022-05-10 19:13
Delcath Systems Ltd. (NASDAQ:DCTH) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants David Hoffman - General Counsel Gerard Michel - Chief Executive Officer Anthony Dias - Vice President of Finance Conference Call Participants Marie Thibault - BTIG Scott Henry - Roth Capital Partners Swayampakula Ramakanth - H.C. Wainwright Operator Good morning, ladies and gentlemen, and welcome to the Delcath’s First Quarter 2022 Earnings Call. At this time, all participants have been placed o ...
Delcath(DCTH) - 2022 Q1 - Quarterly Report
2022-05-10 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-16133 DELCATH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06 ...
Delcath(DCTH) - 2021 Q4 - Annual Report
2022-03-30 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission file number: 001-16133 DELCATH SYSTEMS, INC. Delaware 06-1245881 (State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) ...
Delcath(DCTH) - 2021 Q4 - Earnings Call Transcript
2022-03-25 15:52
Delcath Systems Ltd. (NASDAQ:DCTH) Q4 2021 Earnings Conference Call March 25, 2022 8:30 AM ET Company Participants Gerard Michel - Chief Executive Officer Dr. Johnny John - Senior Vice President, Medical Affairs and Clinical Development Kevin Muir - Vice President, Commercial Operations Anthony Dias - Vice President, Finance David Hoffman - General Counsel Conference Call Participants Marie Thibault - BTIG Yale Jen - Laidlaw & Company Scott Henry - Roth Capital Swayampakula Ramakanth - HC Wainwright Ben Sh ...
Delcath(DCTH) - 2021 Q3 - Earnings Call Transcript
2021-11-09 16:20
Delcath Systems Ltd. (NASDAQ:DCTH) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Gerard Mitchell - Chief Executive Officer Dr. Johnny John - Senior Vice President, Medical Affairs and Clinical Development John Purpura - Chief Operating Officer Christine Padula - Principal Accounting Officer (interim) James Carbonara - Hayden Investor Relations Conference Call Participants Marie Thibault - BTIG Scott Henry - Roth Capital Yale Jen - Laidlaw & Company Operator Good day ladie ...
Delcath(DCTH) - 2021 Q3 - Quarterly Report
2021-11-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-16133 DELCATH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1245881 (Stat ...
Delcath(DCTH) - 2021 Q2 - Earnings Call Transcript
2021-08-10 14:56
Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2021 Earnings Conference Call August 10, 2021 8:30 AM ET Company Participants James Carbonara - Investor Relations Gerard Michel - Chief Executive Officer Christine Padula - Interim Principal Accounting Officer John Purpura - Chief Operating Officer Johnny John - Senior Vice President, Medical Affairs and Clinical Development Conference Call Participants Marie Thibault - BTIG Scott Henry - ROTH Capital Yale Jen - Laidlaw & Company Operator Good day ladies and gentlemen ...
Delcath(DCTH) - 2021 Q2 - Quarterly Report
2021-08-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-16133 DELCATH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1245881 (State or ...
Delcath(DCTH) - 2021 Q1 - Earnings Call Transcript
2021-05-11 17:56
Delcath Systems, Inc. (NASDAQ:DCTH) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants James Carbonara - Investor Relations Gerard Michel - Chief Executive Officer Christine Padula - Interim Principal Accounting Officer John Purpura - Chief Operating Officer Johnny John - Vice President, Clinical and Medical Affairs Kevin Muir - VP, Commercial Operations Conference Call Participants Scott Henry - ROTH Capital Yale Jen - Laidlaw & Company Marie Thibault - BTIG Arlinda Lee - Canacc ...